Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Newer cancer therapies surpass old standards

    • 11 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Newer cancer therapies surpass old standards. Pharmacoecon. Outcomes News 301, 3–4 (2001). https://doi.org/10.1007/BF03269175

    Download citation

    Keywords

    • Acute Myeloid Leukemia
    • Acute Myeloid Leukaemia
    • Conventional Chemotherapy
    • Procarbazine
    • Gemtuzumab Ozogamicin